Advertisement Heraeus - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More


Highly Potent Active Pharmaceutical Ingredients



Heraeus, the precious metals and technology group headquartered in Hanau, Germany, is a global, private company with over 155 years of tradition. Our businesses include precious metals, sensors, biomaterials and medical products, dental products, quartz glass, and specialty light sources.

With product revenues of €2.6 billion and precious metal trading revenues of €13.6 billion, as well as more than 12,300 employees in over 110 subsidiaries worldwide, Heraeus holds a leading position in its global markets.

Industrial precious metals and special metals

Heraeus is a world leader in industrial precious metals and special metals. A global network of companies in Europe, North America, Asia, and Africa includes production facilities for all phases of precious metal production and refining. In addition, Heraeus holds a leading international position in industrial precious metal trading based on decades of expertise.

Based on Heraeus’ know-how in the handling of demanding materials and production processes, the business unit pharmaceutical ingredients has been a preferred API supplier to the pharmaceutical industry around the globe.

High potency oncology molecules

We are specialised in high potency oncology molecules. Today our product portfolio consists of generics and a growing number of exclusive co-operations on new chemical entities. We offer contract development and manufacturing services throughout all phases of a product’s lifecycle – from basic research to large-scale production.

State-of-the-art research and development and production facilities provide technological access to a wide range of chemical and fermentation processes. These capabilities make us an ideal partner to clients from the generic’s sector, as well as innovative pharmaceutical companies.

API development and manufacture

Since the launch of the first API at Heraeus – Cisplatin in 1982 – we have continuously expanded and improved our services for our customers. Beyond sophisticated API development and manufacture, experienced regulatory affairs, quality assurance and quality control groups assure compliance with current ICH guidelines as well as a continuous enhancement of our quality standards. A successful history of GMP certifications by the US FDA and the German health authority dates back to 1988.


W.C. Heraeus GmbH
Chemicals Division
Business Unit Pharmaceutical Ingredients
Heraeusstraße 142-14
63450 Hanau

Tel: +49 (0)6181 – 35 5446
Fax: +49 (0)6181 – 35 4302

Generic Platinum Based APIs and Organic Anti-Cancer Compounds

Having started with generic platinum based APIs –where Heraeus is the largest producer worldwide - Heraeus developed a variety of purely organic anti-cancer compounds. Today, we manufacture organic as well as metal based highly potent APIs for the generic industry or under exclusive contracts.

For broadening our production capabilities, we have set up a unique commercial fermentation facility (incl. state of the art downstream facilities) for highly potent anti-cancer APIs at our Hanau site. All development and production facilities as well as the technical infrastructure meet highest standards of staff, product and environmental protection. Besides development and synthesis of…
Quick Contact Heraeus
Quick Contact Heraeus

Quick Contact Heraeus
Quick Contact Heraeus
Quick Contact Heraeus

Contact Heraeus

Optional Data

Almost there, complete this form and hit the submit button to complete your registration.


Finally, complete a quick security check and confirm terms and conditions:

Quick Contact Heraeus